Philips receives FDA clearance for patch that monitors breathing

Long before the COVID-19 pandemic, Philips General Care head Ravi Kuppuraj and his team were working to develop a device that could quickly determine if a patient is beginning to deteriorate. They developed a disposable patch that could monitor a patient’s respiratory rate and heart rate after they are discharged from the ICU.

The two measurements are the top predictors of patient deterioration, and can be detected well before oxygen saturation levels drop or respiratory rates change.

View this post on